ADC Therapeutics SA (ADCT) stock
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.07 (-4.96%)
Close on Nov 13, 2026Market cap $171.08MP/E –Yield –
ADC Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ADC Therapeutics's enterprise value was -$9.03M on Nov 11, 2026, against $249.56M a year earlier. Over the last 5 years it ranged from -$277.45M to $1.11B, with a median of $27.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$9.03M | -105.5% |
| 2025 | Dec 31, 2025 | $162.83M | – |
| 2024 | Dec 31, 2024 | -$81.86M | – |
| 2023 | Dec 29, 2023 | -$161.19M | – |
| 2022 | Dec 30, 2022 | -$84.31M | -107.6% |
| 2021 | Dec 31, 2021 | $1.11B | -28.3% |
| 2020 | Dec 31, 2020 | $1.55B | – |
See a number that looks wrong?